Utilidad de la TC con baja dosis | 16 SEP 13

Detección del cáncer de pulmón

La detección del cáncer de pulmón con la tomografía computarizada de baja dosis puede reducir la mortalidad global.
Autor/a: Dres. : Linda L. Humphrey, Mark Deffebach, Miranda Pappas, Christina Baumann, Kathryn Artis, Jennifer Priest Mitchell, Bernadette Zakher, Rongwei Fu, Christopher G. Slatore Ann Internal Med. 30/07/2013
INDICE:  1.  | 2. Referencias


1. American Cancer Society. Cancer Facts & Figure 2013. Atlanta, GA: American Cancer Soc; 2013.
2. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Bethesda, MD: National Cancer Institute; 2011.
3. American Cancer Society. Cancer Facts & Figure 2010. Atlanta, GA: American Cancer Soc; 2010.
4. Naff JL, Cote´ ML, Wenzlaff AS, Schwartz AG. Racial differences in cancer risk among relatives of patients with early onset lung cancer. Chest. 2007;131:1289-94. [PMID: 17400658]
5. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE; Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142:233-9. [PMID: 15710956]
6. Jett JR. Current treatment of unresectable lung cancer. Mayo Clin Proc. 1993;68:603-11. [PMID: 8388526]
7. Strauss GM. Screening for lung cancer: an evidence-based synthesis. Surg Oncol Clin N Am. 1999;8:747-74, viii. [PMID: 10452939]
8. Osann KE. Lung cancer in women: the importance of smoking, family history of cancer, and medical history of respiratory disease. Cancer Res. 1991;51:4893-7. [PMID: 1654203]
9. Burns DM. Primary prevention, smoking, and smoking cessation: implications for future trends in lung cancer prevention. Cancer. 2000;89:2506-9. [PMID: 11147637]
10. Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst. 1993;85:457-64. [PMID: 8445673]
11. Tong L, Spitz MR, Fueger JJ, Amos CA. Lung carcinoma in former smokers. Cancer. 1996;78:1004-10. [PMID: 8780538]
12. Centers for Disease Control and Prevention (CDC). Current cigarette smoking among adults - United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61:889-94. [PMID: 23134971]
13. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ. 1996;313:711-5. [PMID: 8819439]
14. Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med. 1986;105:503-7. [PMID: 3752756]
15. Fontham ET, Correa P, Reynolds P, Wu-Williams A, Buffler PA, Greenberg RS, et al. Environmental tobacco smoke and lung cancer in nonsmoking women. A multicenter study. JAMA. 1994;271:1752-9. [PMID: 8196118]
16. Trichopoulos D, Mollo F, Tomatis L, Agapitos E, Delsedime L, Zavitsanos X, et al. Active and passive smoking and pathological indicators of lung cancer risk in an autopsy study. JAMA. 1992;268:1697-701. [PMID: 1527879]
17. Davila DG, Williams DE. The etiology of lung cancer. Mayo Clin Proc. 1993;68:170-82. [PMID: 8423698]
18. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90. [PMID: 21296855]
19. Nesbitt JC, Lee J, Komaki R, Roth JA. Cancer of the lung. In: Holland JF, Bast RC Jr, Morton DL, Frei E III, Kufe DW, Weichselbaum RR, eds. Cancer Medicine. Baltimore; 1997.
20. Henschke CI, Yip R, Miettinen OS; International Early Lung Cancer Action Program Investigators. Women’s susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. JAMA. 2006;296:180-4. [PMID:16835423]
21. U.S. Preventive Services Task Force. Lung cancer screening: recommendation statement. Ann Intern Med. 2004;140:738-9. [PMID: 15126258]
22. Humphrey L, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, et al. Screening for Lung Cancer: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation. Rockville, MD: Agency for Healthcare Research and Quality; 2013.
23. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al; Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20:21-35. [PMID: 11306229]
24. Anderson CM, Yip R, Henschke CI, Yankelevitz DF, Ostroff JS, Burns DM. Smoking cessation and relapse during a lung cancer screening program. Cancer Epidemiol Biomarkers Prev. 2009;18:3476-83. [PMID: 19959698]
25. Ashraf H, Tønnesen P, Holst Pedersen J, Dirksen A, Thorsen H, Døssing M. Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST). Thorax. 2009;64:388-92. [PMID: 19052048]
26. Becker N, Motsch E, Gross ML, Eigentopf A, Heussel CP, Dienemann H, et al. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol. 2012;138:1475-86. [PMID: 22526165]
27. Byrne MM, Weissfeld J, Roberts MS. Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening. Med Decis Making. 2008;28:917- 25. [PMID: 18725404]
28. Chang MY, Mentzer SJ, Colson YL, Linden PA, Jaklitsch MT, Lipsitz SR, et al. Factors predicting poor survival after resection of stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2007;134:850-6. [PMID: 17903494]
29. Christian C, Erica S, Morandi U. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification. Lung Cancer. 2006;54:185-91. [PMID: 16996167]
30. Cox LS, Clark MM, Jett JR, Patten CA, Schroeder DR, Nirelli LM, et al. Change in smoking status after spiral chest computed tomography scan screening. Cancer. 2003;98:2495-501. [PMID: 14635086]
31. Croswell JM, Baker SG, Marcus PM, Clapp JD, Kramer BS. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial. Ann Intern Med. 2010;152:505-12, W176-80. [PMID: 20404381]
32. Croswell JM, Kramer BS, Kreimer AR, Prorok PC, Xu JL, Baker SG, et al. Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Ann Fam Med. 2009;7:212-22. [PMID: 19433838]
33. Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P; Writing Committee, Lung Screening Study Research Group. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest. 2004;126:114-21. [PMID: 15249451]
34. Gohagan JK, Marcus PM, Fagerstrom RM, Pinsky PF, Kramer BS, Prorok PC, et al; LUNG SCREENING STUDY RESEARCH GROUP. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer. 2005;47:9-15. [PMID:15603850]
35. Goodgame B, Viswanathan A, Miller CR, Gao F, Meyers B, Battafarano RJ, et al. A clinical model to estimate recurrence risk in resected stage I non-small cell lung cancer. Am J Clin Oncol. 2008;31:22-8. [PMID: 18376223]
36. Goya T, Asamura H, Yoshimura H, Kato H, Shimokata K, Tsuchiya R, et al; Japanese Joint Committee of Lung Cancer Registry. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Lung Cancer. 2005;50:227-34. [PMID: 16061304]
37. Henschke CI, Yankelevitz DF, Smith JP, Libby D, Pasmantier M, McCauley D, et al. CT screening for lung cancer Assessing a regimen’s diagnostic performance. Clin Imaging. 2004;28:317-21. [PMID: 15471661]
38. Hocking WG, Hu P, Oken MM, Winslow SD, Kvale PA, Prorok PC, et al; PLCO Project Team. Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. J Natl Cancer Inst. 2010;102:722-31. [PMID: 20442215]
39. Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, et al; DANTE Study Group. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med. 2009;180:445-53. [PMID: 19520905]
40. Infante M, Lutman FR, Cavuto S, Brambilla G, Chiesa G, Passera E, et al; DANTE Study Group. Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. Lung Cancer. 2008;59:355-63. [PMID: 17936405]
41. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS; International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355:1763-71. [PMID: 17065637]
42. Kates M, Swanson S, Wisnivesky JP. Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer__1 cm in size: a review of SEER data. Chest. 2011;139:491-6. [PMID: 20576736]
43. Liu X, Liang M, Wang Y, Chen K, Chen X, Qin P, et al. The outcome differences of CT screening for lung cancer pre and post following an algorithm in Zhuhai, China. Lung Cancer. 2011;73:230-6. [PMID: 21168238]
44. Lopes Pegna A, Picozzi G, Mascalchi M, Maria Carozzi F, Carrozzi L, Comin C, et al; ITALUNG Study Research Group. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer. 2009;64:34-40. [PMID: 18723240]
45. MacRedmond R, McVey G, Lee M, Costello RW, Kenny D, Foley C, et al. Screening for lung cancer using low dose CT scanning: results of 2 year follow up. Thorax. 2006;61:54-6. [PMID: 16396954]
46. Maeda H, Matsumura A, Kawabata T, Suito T, Kawashima O, Watanabe T, et al; Japan National Hospital Organization Study Group for Lung Cancer. Adenosquamous carcinoma of the lung: surgical results as compared with squamous cell and adenocarcinoma cases. Eur J Cardiothorac Surg. 2012;41:357-61. [PMID: 21737295]
47. Maeda R, Yoshida J, Ishii G, Hishida T, Aokage K, Nishimura M, et al. Long-term survival and risk factors for recurrence in stage I non-small cell lung cancer patients with tumors up to 3 cm in maximum dimension. Chest. 2010; 138:357-62. [PMID: 20435660]
48. Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst. 2006;98:748-56. [PMID: 16757699]
49. Mascalchi M, Belli G, Zappa M, Picozzi G, Falchini M, Della Nave R, et al. Risk-benefit analysis of X-ray exposure associated with lung cancer screening in the Italung-CT trial. AJR Am J Roentgenol. 2006;187:421-9. [PMID: 16861547]
50. Mascalchi M, Mazzoni LN, Falchini M, Belli G, Picozzi G, Merlini V, et al. Dose exposure in the ITALUNG trial of lung cancer screening with low-dose CT. Br J Radiol. 2012;85:1134-9. [PMID: 21976631]
51. McKenna RJ Jr, Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg. 2006;81:421-5. [PMID: 16427825]
52. Menezes RJ, Roberts HC, Paul NS, McGregor M, Chung TB, Patsios D, et al. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. Lung Cancer. 2010;67:177-83. [PMID:19427055]
53. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395-409. [PMID: 21714641]
54. Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg. 2006;132:769-75. [PMID: 17000286]
55. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, et al. Evolution of surgical outcomes for nonsmall cell lung cancer: time trends in 1465 consecutive patients undergoing complete resection. Ann Thorac Surg. 2004;77:1926-30. [PMID: 15172237]
56. Oken MM, Hocking WG, Kvale PA, Andriole GL, Buys SS, Church TR, et al; PLCO Project Team. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 2011;306:1865-73. [PMID: 22031728]
57. Pastorino U, Rossi M, Rosato V, Marchiano` A, Sverzellati N, Morosi C, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 2012;21:308-15. [PMID:22465911]
58. Pedersen JH, Ashraf H, Dirksen A, Bach K, Hansen H, Toennesen P, et al. The Danish randomized lung cancer CT screening trial—overall design and results of the prevalence round. J Thorac Oncol. 2009;4:608-14. [PMID:19357536]
59. Pinsky PF, Marcus PM, Kramer BS, Freedman M, Nath H, Kvale P, et al. Diagnostic procedures after a positive spiral computed tomography lung carcinoma screen. Cancer. 2005;103:157-63. [PMID: 15529306] 60. Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clementsen PF, et al. CT screening for lung cancer brings forward early disease. The randomized Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax. 2012;67:296-301. [PMID: 22286927]
61. Sawabata N, Miyaoka E, Asamura H, Nakanishi Y, Eguchi K, Mori M, et al; Japanese Joint Committee for Lung Cancer Registration. Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol. 2011;6:1229-35. [PMID: 21610521]
62. Shemesh J, Henschke CI, Farooqi A, Yip R, Yankelevitz DF, Shaham D, et al. Frequency of coronary artery calcification on low-dose computed tomography screening for lung cancer. Clin Imaging. 2006;30:181-5.  [PMID:16632153]
63. Shirvani SM, Jiang J, Chang JY, Welsh JW, Gomez DR, Swisher S, et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys. 2012;84:1060-70. [PMID: 22975611]
64. Sinicrope PS, Rabe KG, Brockman TA, Patten CA, Petersen WO, Slusser J, et al. Perceptions of lung cancer risk and beliefs in screening accuracy of spiral computed tomography among high-risk lung cancer family members. Acad Radiol. 2010;17:1012-25. [PMID: 20599157]
65. Strand TE, Rostad H, Møller B, Norstein J. Survival after resection for primary lung cancer: a population based study of 3211 resected patients. Thorax. 2006;61:710-5. [PMID: 16601091]
66. Styn MA, Land SR, Perkins KA, Wilson DO, Romkes M, Weissfeld JL. Smoking behavior 1 year after computed tomography screening for lung cancer: effect of physician referral for abnormal CT findings. Cancer Epidemiol Biomarkers Prev. 2009;18:3484-9. [PMID: 19959699]
67. Swensen SJ, Jett JR, Hartman TE, Midthun DE, Mandrekar SJ, Hillman SL, et al. CT screening for lung cancer: five-year prospective experience. Radiology. 2005;235:259-65. [PMID: 15695622]
68. Taylor KL, Cox LS, Zincke N, Mehta L, McGuire C, Gelmann E. Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer. 2007;56:125-34. [PMID: 17196298]
69. Townsend CO, Clark MM, Jett JR, Patten CA, Schroeder DR, Nirelli LM, et al. Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer. 2005;103:2154-62. [PMID: 15825210]
70. Toyoda Y, Nakayama T, Kusunoki Y, Iso H, Suzuki T. Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography. Br J Cancer. 2008;98:1602-7. [PMID: 18475292]
71. Tsushima K, Sone S, Hanaoka T, Kubo K. Radiological diagnosis of small pulmonary nodules detected on low-dose screening computed tomography. Respirology. 2008;13:817-24. [PMID: 18811880]
72. van den Bergh KA, Essink-Bot ML, Borsboom GJ, Scholten ET, van Klaveren RJ, de Koning HJ. Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial. Eur Respir J. 2011;38:154-61. [PMID: 21148229]
73. van den Bergh KA, Essink-Bot ML, Borsboom GJ, Th Scholten E, Prokop M, de Koning HJ, et al. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer. 2010;102:27-34. [PMID: 19935789]
74. van den Bergh KA, Essink-Bot ML, van Klaveren RJ, de Koning HJ. Informed participation in a randomised controlled trial of computed tomography screening for lung cancer. Eur Respir J. 2009;34:711-20. [PMID: 19282345]
75. van der Aalst CM, van den Bergh KA, Willemsen MC, de Koning HJ, van Klaveren RJ. Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial. Thorax. 2010;65:600-5. [PMID: 20627916]
76. van der Aalst CM, van Klaveren RJ, van den Bergh KA, Willemsen MC, de Koning HJ. The impact of a lung cancer computed tomography screening result on smoking abstinence. Eur Respir J. 2011;37:1466-73. [PMID: 21148233]
77. van Iersel CA, de Koning HJ, Draisma G, Mali WP, Scholten ET, Nackaerts K, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomized lung cancer multi-slice CT screening trial (NELSON). Int J Cancer. 2007;120:868-74. [PMID: 17131307]
78. van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009;361:2221-9. [PMID: 19955524]
79. Van’t Westeinde SC, Horeweg N, De Leyn P, Groen HJ, Lammers JW, Weenink C, et al. Complications following lung surgery in the Dutch-Belgian randomized lung cancer screening trial. Eur J Cardiothorac Surg. 2012;42:420-9. [PMID: 22491665]
80. Veronesi G, Bellomi M, Mulshine JL, Pelosi G, Scanagatta P, Paganelli G, et al. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer. 2008;61:340-9. [PMID: 18308420]
81. Veronesi G, Bellomi M, Scanagatta P, Preda L, Rampinelli C, Guarize J, et al. Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program. J Thorac Cardiovasc Surg. 2008;136:611-7. [PMID: 18805261]
82. Veronesi G, Maisonneuve P, Bellomi M, Rampinelli C, Durli I, Bertolotti R, et al. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med. 2012;157:776-84. [PMID: 23208167]
83. Wagnetz U, Menezes RJ, Boerner S, Paul NS, Wagnetz D, Keshavjee S, et al. CT screening for lung cancer: implication of lung biopsy recommendations. AJR Am J Roentgenol. 2012;198:351-8. [PMID: 22268177]
84. Wilson DO, Weissfeld JL, Fuhrman CR, Fisher SN, Balogh P, Landreneau RJ, et al. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med. 2008; 178:956-61. [PMID: 18635890]
85. Xu DM, Gietema H, de Koning H, Vernhout R, Nackaerts K, Prokop M, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer. 2006;54:177-84. [PMID: 16989922]
86. Kaerlev L, Iachina M, Pedersen JH, Green A, Nørgård BM. CT-Screening for lung cancer does not increase the use of anxiolytic or antidepressant medication. BMC Cancer. 2012;12:188. [PMID: 22621716]
87. Aggestrup LM, Hestbech MS, Siersma V, Pedersen JH, Brodersen J. Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial. BMJ Open. 2012;2:e000663. [PMID: 22382119]
88. Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, Duan F, et al; National Lung Screening Trial Research Team. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med. 2013;368:1980-91. [PMID: 23697514]
89. Henschke CI, Yip R, Yankelevitz DF, Smith JP; International Early Lung Cancer Action Program Investigators. Definition of a positive test result in computed tomography screening for lung cancer: a cohort  study. Ann Intern Med. 2013;158:246-52. [PMID: 23420233]
90. Bach PB, Gould MK. When the average applies to no one: personalized decision making about potential benefits of lung cancer screening. Ann Intern Med. 2012;157:571-3. [PMID: 22893040]
91. Chan CK, Wells CK, McFarlane MJ, Feinstein AR. More lung cancer but better survival. Implications of secular trends in “necropsy surprise” rates. Chest. 1989;96:291-6. [PMID: 2787730]
92. Flehinger BJ, Kimmel M, Polyak T, Melamed MR.  screening for lung cancer. The Mayo Lung Project revisited. Cancer. 1993;72:1573-80. [PMID:8394199]
93. Sobue T, Suzuki T, Matsuda M, Kuroishi T, Ikeda S, Naruke T. Survival for clinical stage I lung cancer not surgically treated. Comparison between screendetected and symptom-detected cases. The Japanese Lung Cancer Screening Research Group. Cancer. 1992;69:685-92. [PMID: 1730119]
94. O’Connor GT, Hatabu H. Lung cancer screening, radiation, risks, benefits, and uncertainty [Editorial]. JAMA. 2012;307:2434-5. [PMID: 22692175]
95. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012;307:2418-29. [PMID: 22610500]
96. Aberle DR, Adams AM, Berg CD, Clapp JD, Clingan KL, Gareen IF, et al; National Lung Screening Trial Research Team. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst. 2010;102:1771-9. [PMID: 21119104]
97. Raji OY, Duffy SW, Agbaje OF, Baker SG, Christiani DC, Cassidy A, et al. Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study. Ann Intern Med. 2012;157:242-50. [PMID: 22910935]
98. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:347-60. [PMID: 12204020]
99. Nelson H, Tyne K, Naik A, Bougatsos C, Chan B, Nygren P, et al. Screening for Breast Cancer: Systematic Evidence Review Update for the U. S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality; 2009. Report 10-05142-EF-1.
100. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al; PLCO Project Team. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366:2345-57. [PMID:22612596]



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2023